Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial

Published:2016-10 Issue:10 Volume:4 Page:797-806
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

O'Byrne Paul M,Metev Hristo,Puu Margareta,Richter Kai,Keen Christina,Uddin Mohib,Larsson Bengt,Cullberg Marie,Nair Parameswaran

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference30 articles.

1. Non-eosinophilic corticosteroid unresponsive asthma;Pavord;Lancet,1999

2. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma;Berry;Thorax,2007

3. Pathophysiology of severe asthma;Busse;J Allergy Clin Immunol,2000

4. Targeting TNF-alpha: a novel therapeutic approach for asthma;Brightling;J Allergy Clin Immunol,2008

5. Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities;Holgate;J Allergy Clin Immunol,2006

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil and neutrophil extracellular trap involvement in neutrophilic asthma: A review;Medicine;2024-08-23

2. Asthma Pathogenesis: Phenotypes, Therapies, and Gaps: Summary of the Aspen Lung Conference 2023;American Journal of Respiratory Cell and Molecular Biology;2024-08

3. Immunological factors, important players in the development of asthma;BMC Immunology;2024-07-26

4. Selective anti-CXCR2 receptor blockade by AZD5069 inhibits CXCL8-mediated pro-tumorigenic activity in human thyroid cancer cells in vitro;Journal of Endocrinological Investigation;2024-06-20

5. A microphysiological system reveals neutrophil contact-dependent attenuation of pancreatic tumor progression by CXCR2 inhibition-based immunotherapy;Scientific Reports;2024-06-19